Indivior shares crash 70% after US indictment over opioid scheme

The Slough-based company is accused of engaging in an illegal scheme to boost prescriptions of its opioid addiction treatment. In 2014, it span off from Reckitt Benckiser which is distancing itself from Invidior, after RB shares also fell.